Characterization of Cathepsin B in Mediating Silica Nanoparticle-Induced Macrophage Pyroptosis via an NLRP3-Dependent Manner

Abstract

Silica nanoparticles (SiNPs) are one of the most widely used inorganic nanomaterials, and exposure to SiNP has been demonstrated to induce pulmonary inflammation, primarily promoted by the NLRP3-mediated macrophage pyroptosis. However, mechanisms underlying the activation of NLRP3 signaling are complex, and whether cathepsin B (CTSB), an enzyme released by the ruptured lysosome, could trigger NLRP3 assembly is controversial. Methods: To further characterize the role of CTSB in silica-induced pyroptosis, we conducted this study by establishing SiNP exposure models in vitro. The morphological features of SiNPs were exhibited by the SEM and TEM, and the effects of SiNPs' internalization on macrophages were examined by the TEM and immunofluorescent staining. Moreover, Western blot was performed to detect the expression of proteins related to pyroptosis and CTSB after blocking the expression of NLRP3 and CTSB. Results: We found that SiNPs internalization caused the rupture of macrophage membrane and promoted the aging of cells with increased intracellular vacuoles. Also, the expression of NLRP3, ASC, Caspase-1, GSDMD, Pro-IL-1β, IL-1β, and CTSB increased under the stimulation of SiNP, which could be suppressed by additional treatment with MCC950, an NLRP3-specific inhibitor. Besides, we found SiNP joint treatment with leupeptin, a CTSB inhibitor, could inhibit the expression of CTSB, but it had no effect on the expression of NLRP3, ASC, and Caspase-1, and the process of macrophage pyroptosis was also not affected. Conclusion: SiNP exposure induces rupture of macrophages and the release of lysosomal CTSB, but CTSB fails to specifically act on the NLRP3 inflammasome to induce pyroptosis which is causally linked to lung inflammation and fibrosis.

Poly(allylamine)/tripolyphosphate nanocomplex coacervate as a NLRP3-dependent systemic adjuvant for vaccine development

“…Remarkably, we did not observe the Np internalization in non-phagocytic mucosa epithelial cells. The permeabilization of the lysosomal membrane is one of the most frequently described mechanisms for activating the inflammasome by particles and Np 47, 48 . We used several inhibitors to confirm the role of the different components of the pathway, and we corroborated the participation of cathepsin B as the early activator of the inflammasome 49, 50 .…”

Dual viscosity mixture vehicle for intratympanic steroid treatment modifies the ROS and inflammation related proteomes

“…The peptides generated by those proteasomal protein substrates were transported to the ER by the antigen presentation complex (TAP). In the MHC class Ⅱ pathway, the cathepsin B (CTSB) protein—which plays the role of a pro-inflammatory molecule through activating NLRP3 inflammasome ( Ma et al, 2022 ), was downregulated after IT steroid treatments with DVV. In addition, the DEPs related to the complement cascade pathway were also downregulated after IT steroid treatment.…”

Mechanism of NLRP3 inflammasome intervention for synovitis in knee osteoarthritis: A review of TCM intervention

“…And promoting the release of calcium ions can aggravate the injury of mitochondria, and calcium ion-mediated mitochondrial damage could cause the activation of NLRP3 inflammasome ( Murakami et al, 2012 ). Lysosomal damage releases cathepsin B directly binds to the NLRP3 inflammasome and promotes the activation of the NLRP3 inflammasome ( Ma et al, 2022 ). The release of mitochondrial ROS (mt ROS) and mitochondrial DNA (mt DNA) caused by mitochondrial dysfunction is another important cause of NLRP3 inflammasome activation.…”